Klimas, N G, Salvato, F R, Morgan, R et al. · Journal of clinical microbiology · 1990 · DOI
This study examined immune system markers in 30 ME/CFS patients and compared them to healthy controls. Researchers found that patients had multiple immune system abnormalities, with the most consistent problem being that natural killer cells—white blood cells that fight infections and cancer—were not working properly, even though patients had more of these cells than normal. Patients also showed reduced responses to immune stimulation and changes in other types of immune cells.
This study provided early evidence that ME/CFS involves objective, measurable immune system dysfunction rather than psychiatric causes, which was important for validating the biological basis of the illness. Identifying specific immune abnormalities like impaired NK cell function has guided subsequent research into potential mechanisms and therapeutic targets for ME/CFS.
This cross-sectional study cannot establish causation or determine whether immune abnormalities are the cause or consequence of ME/CFS. The study does not prove that viral reactivation causes ME/CFS, only that the observed immune pattern is compatible with that hypothesis. Additionally, cross-sectional design means we cannot determine whether these immune changes persist over time or correlate with symptom severity.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →